2. Surveillance of AMR in Finland
• Communicable Diseases Act (1227/2016) requires comprehensive surveillance of AMR.
• Surveillance at national level and developing indicators are mainly THL’s responsibility (also in
National Action Plan)
• Participation in international surveillance systems
• EARS-net (ECDC)
• other networks conducted ECDC/EFSA that collect AMR data
• GLASS (WHO)
26.2.2020 2
3. National action plan on AMR
26.2.2020 3
2000 2017
• Finland updated its plan on May 2017
• Ministry of Social Affairs and Health
• National Institute for Health and Welfare (THL)
• Ministry of Agriculture and Forestry
• Finnish Food Authority (Ruokavirasto)
• Several stakeholders
• http://urn.fi/URN:ISBN:978-952-00-3965-3
4. Organization of AMR Surveillance in Finland
4
• Finres:
• National antimicrobial susceptibility
database (THL)
• 19 clinically important
bacteria/antimicrobials
• Including MRSA, VRE, ESBL, (CPE)
• Infections
• 287 000 isolates / year
• 2 000 000 tests / year
• Coverage of blood cultures over 98%
• FiRe: (Finnish study group for
antimicrobial resistance)
• Network, since 1992
• Harmonization of susceptibility
testing and collection of data
• All clinical microbiology
laboratories (23)
• Including private laboratories
• THL mycobacterium laboratory
www.finres.fi
26.2.2020
NIDR: MDRs, PPS
14. Finnish Institute for Health and Welfare
Antimicrobial consumption in Finland
2011-2018
Jari Jalava, PhD
26.2.2020
15. ESAC-Net
European Surveillance of Antimicrobial Consumption Network
• Finland has participated since 1997
• Systemic antimicrobials (no topical products)
• Community and hospital sector reported separately
• Indicator: yearly number of DDD per 1000 inhabitants per
day
• Finnish data
• Number of packages per treatment per HD
• Three largest wholesalers ->
≃ 100 % of total medicine sales in Finland
4.3.2020 15
16. ESAC-Net data
• From different/ multiple sources
– NOT comparable between countries
4.3.2020 16
AC: community consumption
HC: hospital consumption
S: sales data
R: reimbursement data
B: both S & R
20. Regional consumption in Finland
• Finnish data is available also by hospital district (N=20)
• Consumption per population (DDD/ day/ 1000 inhabitants)
• Consumption trends
• Average change per year
• Change according to a linear regression model
• Distribution of antimicrobial agents consumed
26.2.2020
24. Consumption of specific antibacterials used for the treatment of
patients infected with multidrug-resistant bacteria
(J01CR05, J01DH, J01XB), Finland, 2011-2018
4.3.2020 24
29. Future developing plans for AMC surveillance
• Annual national report in November (around EAAD)
• Finnish Institute for Health and Welfare
• Reporting hospital and community consumption separately
• Finnish Medicines Agency Fimea
• Better separation of hospital/community consumption
• Community consumption reporting population-based
• Hospital consumption reporting in relation to hospital-days
• Reporting AMC according to age groups – re-imbursement data utilization(?)
• Social Insurance Institution of Finland
26.2.2020
31. Finnish Institute for Health and Welfare
Antimicrobial consumption in Finland
2011-2018
Jari Jalava, PhD
26.2.2020
32. ESAC-Net
European Surveillance of Antimicrobial Consumption Network
• Finland has participated since 1997
• Systemic antimicrobials (no topical products)
• Community and hospital sector reported separately
• Indicator: yearly number of DDD per 1000
inhabitants per day
• Finnish data
• Number of packages per treatment per HD
• Three largest wholesalers ->
≃ 100 % of total medicine sales in Finland 4.3.2020 32
33. ESAC-Net data
• From different/ multiple sources
– NOT comparable between countries
4.3.2020 33
AC: community consumption
HC: hospital consumption
S: sales data
R: reimbursement data
B: both S & R
37. Regional consumption in Finland
• Finnish data is available also by hospital district (N=20)
• Consumption per population (DDD/ day/ 1000 inhabitants)
• Consumption trends
• Average change per year
• Change according to a linear regression model
• Distribution of antimicrobial agents consumed
26.2.2020
41. Consumption of specific antibacterials used for the treatment of
patients infected with multidrug-resistant bacteria
(J01CR05, J01DH, J01XB), Finland, 2011-2018
4.3.2020 41
46. Future developing plans for AMC surveillance
• Annual national report in November (around EAAD)
• Finnish Institute for Health and Welfare
• Reporting hospital and community consumption separately
• Finnish Medicines Agency Fimea
• Better separation of hospital/community consumption
• Community consumption reporting population-based
• Hospital consumption reporting in relation to hospital-days
• Reporting AMC according to age groups – re-imbursement data utilization(?)
• Social Insurance Institution of Finland
26.2.2020